Primary and Secondary Prevention of Sudden Cardiac Death: Who Should Get an ICD?

Overview

Journal Heart

Date 2007 Oct 16

PMID 17934011

Citations 6

Authors

Massimo Santini

Carlo Lavalle

Renato Pietro Ricci

Affiliations

Soon will be listed here.

Citing Articles

Dimensional structure of the Brief Illness Perception Questionnaire and Association with adverse childhood experiences in patients with an implantable cardioverter-defibrillator.

Dorner M, von Kanel R, Pazhenkottil A, Altwegg R, Konig N, Nager L Sci Rep. 2025; 15(1):3731.

PMID: 39880904 PMC: 11779862. DOI: 10.1038/s41598-025-88470-x.

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death.

Casolo G, Gulizia M, Aschieri D, Chinaglia A, Corda M, Nassiacos D Eur Heart J Suppl. 2023; 25(Suppl D):D294-D311.

PMID: 37213799 PMC: 10194821. DOI: 10.1093/eurheartjsupp/suad101.

Benefits of support groups for patients living with implantable cardioverter defibrillators: a mixed-methods systematic review and meta-analysis.

Sanders K, Chousou P, Carver K, Pugh P, Degens H, Azzawi M Open Heart. 2022; 9(2).

PMID: 36252993 PMC: 9577922. DOI: 10.1136/openhrt-2022-002021.

Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.

Lee T, Qian M, Mu L, Di Tullio M, Graham S, Mann D ESC Heart Fail. 2019; 6(2):297-307.

PMID: 30816013 PMC: 6437435. DOI: 10.1002/ehf2.12407.

Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.

Schupp T, Akin I, Reiser L, Bollow A, Taton G, Reichelt T Clin Res Cardiol. 2019; 108(8):878-891.

PMID: 30756152 DOI: 10.1007/s00392-019-01416-y.

References

BIGGER Jr J . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997; 337(22):1569-75. DOI: 10.1056/NEJM199711273372201. View

MOSS A, Hall W, Cannom D, Daubert J, Higgins S, Klein H . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335(26):1933-40. DOI: 10.1056/NEJM199612263352601. View

Wever E, Hauer R, van Capelle F, Tijssen J, Crijns H, Algra A . Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1995; 91(8):2195-203. DOI: 10.1161/01.cir.91.8.2195. View

Becker L, Smith D, Rhodes K . Incidence of cardiac arrest: a neglected factor in evaluating survival rates. Ann Emerg Med. 1993; 22(1):86-91. DOI: 10.1016/s0196-0644(05)80257-4. View

Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G . A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999; 341(25):1882-90. DOI: 10.1056/NEJM199912163412503. View

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M . Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000; 101(14):1660-4. DOI: 10.1161/01.cir.101.14.1660. View

Hohnloser S, Ikeda T, Bloomfield D, Dabbous O, Cohen R . T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet. 2003; 362(9378):125-6. DOI: 10.1016/s0140-6736(03)13865-2. View

10.

. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83. DOI: 10.1056/NEJM199711273372202. View

11.

Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R . Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101(11):1297-302. DOI: 10.1161/01.cir.101.11.1297. View

12.

Hohnloser S, Kuck K, Dorian P, Roberts R, Hampton J, Hatala R . Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004; 351(24):2481-8. DOI: 10.1056/NEJMoa041489. View

13.

Bloomfield D, Steinman R, Namerow P, Parides M, Davidenko J, Kaufman E . Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004; 110(14):1885-9. DOI: 10.1161/01.CIR.0000143160.14610.53. View

14.

Bristow M, Saxon L, Boehmer J, Krueger S, Kass D, De Marco T . Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350(21):2140-50. DOI: 10.1056/NEJMoa032423. View

15.

Kuck K, Cappato R, Siebels J, Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54. DOI: 10.1161/01.cir.102.7.748. View

16.

Anderson J, Hallstrom A, EPSTEIN A, Pinski S, Rosenberg Y, Nora M . Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation. 1999; 99(13):1692-9. DOI: 10.1161/01.cir.99.13.1692. View

17.

Hallstrom A, Eisenberg M, Bergner L . The persistence of ventricular fibrillation and its implication for evaluating EMS. Emerg Health Serv Q. 1983; 1(4):41-9. DOI: 10.1300/j260v01n04_08. View

18.

Wilber D, Zareba W, Hall W, Brown M, Lin A, Andrews M . Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004; 109(9):1082-4. DOI: 10.1161/01.CIR.0000121328.12536.07. View